menu toggle

Insights

Perspective, tips, and resources for moving health forward

abstract-brand-colors-texture-2
All Insights Health Systems Pharmacies Physician Practices Manufacturers Animal Health
AmerisourceBergen

Q&A – Future challenges and predictions for CGT patient focused solutions

Inverted color AmerisourceBergen icon
AmerisourceBergen
September 2023

Manufacturers

Podcast: Industry led product development in a rapidly changing CGT landscape

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2023
Autologous cell and gene therapies

Manufacturers

Essential guide to cell and gene therapy (CGT)  commercialization

Inverted color AmerisourceBergen icon
AmerisourceBergen
July 2023
Rainbow-Abstract

Manufacturers

Podcast: The future is bright; the future is CGT

headshot
Lung-I Cheng
Biopharma Services
June 2023
podcast

Manufacturers

Report: Creating a sustainable business model for cell and gene therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
June 2023
cgt

Manufacturers

How innovations in cryologistics support patient access to advanced therapies

Andrea_Zobel Square HR
Andrea Zobel
World Courier
June 2023
Abstract

Manufacturers

Improving Access and Support for Cell and Gene Therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
June 2023
playbook cover

Manufacturers

Q&A: The evolution of the cell and gene therapy field

AB-TB-Sq-Block
AmerisourceBergen
May 2023
Pharma 2023 - 3

Manufacturers

Recap Asembia 2023: Our impactful contributions to the premier specialty pharmacy conference

Inverted color AmerisourceBergen icon
AmerisourceBergen
May 2023
Amerisourcebergen representatives at Asembia

Manufacturers

Three opportunities and three challenges in the cell and gene therapy market

headshot
Lung-I Cheng
Biopharma Services
April 2023
insights

Manufacturers

Recap AMCP 2023: Our thought leadership in action

Inverted color AmerisourceBergen icon
Xcenda
March 2023
Team members at the AMCP 2023 exhibit

On-demand webinar: Dangerous goods classification of cell and gene therapies

Andrea_Zobel Square HR
Andrea Zobel; Claudia Pierenz
World Courier
March 2023
Hazard sign

Delivering advanced CGT biologic breakthroughs to the world

Andrea_Zobel Square HR
Andrea Zobel
World Courier
March 2023
GettyImages-1161024014-RGB_PNG

Infographic: How cryogenic logistics overcome the low tolerance for deviations of cell and gene therapies

Andrea_Zobel Square HR
Andrea Zobel
World Courier
March 2023
shutterstock_524319070

Why location monitoring matters: Amelia's journey with spinal muscular atrophy (SMA)

Inverted color AmerisourceBergen icon
AmerisourceBergen
March 2023
shutterstock_1088838263LR

Evolving advanced therapy medicinal product regulations require new logistics complexity

Andrea_Zobel Square HR
Andrea Zobel
World Courier
February 2023
Regualatory article 2

Regulators tightening cell and gene therapies logistics controls to assure patient safety and security

Andrea_Zobel Square HR
Andrea Zobel
World Courier
February 2023
Regulatory article 3

Time to adapt Europe’s evolving cell and gene therapy regulatory framework before it prevents patient access due to logistics hurdles

Andrea_Zobel Square HR
Andrea Zobel
World Courier
February 2023
Image of European Medicines Agency head office sign

Manufacturers

Three questions biopharma companies must ask when building a cell and gene commercialization strategy

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2023
Cell and gene therapy commercialization

Manufacturers

In conversation with TrakCel: Why successful partnerships can help accelerate advanced therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2023
Accelerating advanced therapies

Manufacturers

Interview: Increasing advanced therapies’ connectivity and speed to market through partnership

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2023
Partnership on CGTs

Our global advanced therapy medical product charging stations and capabilities

Andrea_Zobel Square HR
Andrea Zobel
World Courier
January 2023
New Article map image

With landmark approval, spotlight on cryogenic logistics intensifies

Andrea_Zobel Square HR
Andrea Zobel
World Courier
January 2023
blue genes

Manufacturers

Webinar: Evaluate alternative revolutionary reimbursement models to craft a sustainable business model for cell and gene therapies

A photo of David Senior wearing a dark gray suit, white collared shirt, and dark blue tie with a diamond pattern
David Senior
AmerisourceBergen
December 2022
Cell and Gene therapy alternative reimbursement models

Preserving cell and gene integrity in the supply chain

JenniferF
Jennifer Fenwick
World Courier
December 2022
GettyImages-1198271727_RGB_Large_JPG

Manufacturers

Evaluating alternative revolutionary reimbursement models to craft a sustainable business model for cell and gene therapies

A photo of David Senior wearing a dark gray suit, white collared shirt, and dark blue tie with a diamond pattern
David Senior
AmerisourceBergen
October 2022
Reimbursement models for CGT

Cold hard facts about cryogenic cell and gene therapy logistics

Inverted color AmerisourceBergen icon
World Courier
October 2022
GettyImages-1161024014-RGB_PNG

Fresh or frozen - understanding the supply chain needs of your cell and gene therapy

Andrea_Zobel Square HR
Andrea Zobel
World Courier
August 2022
shutterstock_1241172154 LR

Manufacturers

Alternate payer engagement models are changing the landscape

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2022
Cell and gene therapy Alternate payer engagement models

Manufacturers

Navigating reimbursement and access challenges for novel cell and gene therapies

AB-TB-Sq-Block
Amanda OHora
July 2022
Business meeting

Round table recording: To freeze or not to freeze - challenges and innovations in cell therapy logistics

Andrea_Zobel Square HR
Andrea Zobel
World Courier
July 2022
Speakers live round table cgt

Manufacturers

Getting the right drug to the right patient at the right place at the right time

Inverted color AmerisourceBergen icon
AmerisourceBergen
June 2022
Cell and gene therapy commercialization

Manufacturers

Webinar slides: Navigating Reimbursement and Access Challenges for Novel Cell and Gene Therapies

AB-TB-Sq-Block
Tasmina Hydery
June 2022
abstract lines

Report: Building successful cell and gene therapy supply chains

Inverted color AmerisourceBergen icon
AmerisourceBergen
May 2022
CGT cells

Podcast: Emerging cell and gene therapies, complex logistics eco-systems, and the need for greater industry collaboration

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2022
GettyImages-483533237_RGB_Large_JPG (1)

The time is now: why it pays to be prepared for the commercialization of advanced therapies

Inverted color AmerisourceBergen icon
World Courier
March 2022
ICS_Brooks_3PL_Cryogenic_074_rgb_rtchd LR

Manufacturers

Managing clinical supply chain complexity for cell and gene therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
January 2022
Cell and gene therapy cryogenic storage

Manufacturers

How to optimize the commercial supply chain for cell and gene therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
January 2022
Cell and gene therapy cryo storage

White paper: Setup a robust and scalable supply chain for Cell and Gene Therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
January 2022
shutterstock_1059994115

Manufacturers

Webinar: Key insights on the clinical to commercial transition for autologous therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
September 2021
Autologous cell and gene therapies

Manufacturers

Webinar: Commercial supply chain strategies for cell and gene therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2021
Commercial supply chain strategies for cell and gene therapies

Manufacturers

Webinar | Cell and gene therapies: Clinical supply chain considerations

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2021
optimal cell and gene therapy supply chain and tracking outcomes

Manufacturers

What manufacturers need to know about reimbursement and patient support for cell and gene therapies

Stojanovska_Ana
Ana Stojanovska; Myra Reinhardt
Biopharma Services
July 2021
abstract-brand-colors-texture

Video: How to build a cryogenic logistics platform for allogeneic therapies

Andrea_Zobel Square HR
Andrea Zobel
World Courier
June 2021
Andrea Zobel ISCT

Manufacturers

On-demand webinar: Success factors for commercializing rare disease and orphan drugs

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2021
Commercializing rare and orphan disease products

Manufacturers

On demand webinar: Considerations for the commercialization of cell and gene therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
March 2021
Considerations for the commercialization of cell and gene therapies

Case study: "The last 100m" - Managing the logistics of advanced therapies in an acute NHS hospital setting

NAATTC logo 248
NA-ATTC
ATTC
March 2021
NAATC post

Webinar on-demand: Partnering in a pandemic, a case study by World Courier and Pluristem

KF image
Kelly Frend
World Courier
February 2021
lungs covid19

Manufacturers

Cell and gene therapies: bringing innovation to market

Inverted color AmerisourceBergen icon
AmerisourceBergen
December 2020
Lab tech with DNA

Whitepaper: Key Strategies for Cell and Gene Therapy in China

Portrait of Alex Guite.
Alex Guite
World Courier
November 2020
WC_China_2016_0056-rev_RGB_Large_JPG LR

E-book: Delivering innovation, improving lives

Inverted color AmerisourceBergen icon
AmerisourceBergen
December 2019
Doctor with patient

Article: Advanced Therapy Commercial Supply Chain Lessons for Clinical Trial Success

A portrait of Simon Eliison.
Simon Ellison
World Courier
June 2019
woman looking through microscope

Manufacturers

The Supply Chain Redefined: Cell and Gene Therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
July 2018

Much of the complexity of the cell and gene supply chain comes from how dependent the commercialization phase is on the clinical phase. What does integration look like, and how can the right logistics partner help?

Manufacturers

Financial Management for Cell and Gene Therapies

Albert Cooksey, Senior Vice President and General Manager, 3PL Services, ICS
Albert Cooksey
July 2018

How third-party logistics (3PL) solutions can help cell and gene therapy manufacturers manage the financial aspects of launching new therapies.

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part One

Stojanovska_Ana
Ana Stojanovska
Biopharma Services
June 2018

An executive Q&A on challenges and opportunities related to reimbursement, coding and coverage for cell and gene therapies.

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part Two

Stojanovska_Ana
Ana Stojanovska
Biopharma Services
June 2018

An executive Q&A on the role of data and the future of innovative reimbursement modeling for cell and gene therapies.

Manufacturers

Rethink: Payer Strategies for Commercializing Cell and Gene Therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2018
Rethink: Payer Strategies for Commercializing Cell and Gene Therapies

Manufacturers

Rethinking Reimbursement and Patient Support Following Medical Innovation

Inverted color AmerisourceBergen icon
AmerisourceBergen
January 2018

How can manufacturers approach reimbursement and patient support for cell and gene therapies and other medical innovations?

Manufacturers

Logistics Decisions Will Impact the Success of New Cell and Gene Therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
July 2017

In supply chain decisions, a wholly new type of product demands a wholly new definition for supply chain expertise and effective support.

Manufacturers

Commercializing Cell and Gene Therapies

Inverted color AmerisourceBergen icon
AmerisourceBergen
July 2017

Learn what it takes to design an effective commercialization strategy and execute an integrated solution when the patient is in the supply chain.